The 2008 International Guidelines for Management of Severe Sepsis and Septic Shock: merits and weaknesses

被引:0
作者
Antonelli, M. [1 ]
Mercurio, G. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Anesthesiol & Intens Care, A Gemelli Polyclin, Rome, Italy
关键词
Health planning guidelines; Sepsis; Shock; septic; SURVIVING SEPSIS; THERAPY; HYDROCORTISONE; CAMPAIGN; TRIAL;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The Guidelines are intended to provide standard guidance for the care of patients by grouping evidence-based interventions into bundles that can be easily used by clinicians to improve patient outcome. The 2008 International guidelines for management of severe sepsis and septic shock is a large and extraordinary update of the literature offered by current leaders in the Field. Unfortunately, as a consensus of experts, most of whom expressed their opinions by voting, these guidelines do not always represent the state of the art. Furthermore, they can change if new participants take part in the process. By considering the merits and weaknesses of practice guidelines, we Conclude that guidelines cannot replace a physician's judgments, but rather Should be a starting point for more robust and proficient scientific evidence.
引用
收藏
页码:27 / 29
页数:3
相关论文
共 16 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis [J].
Annane, D ;
Bellissant, E ;
Bollaert, PE ;
Briegel, J ;
Keh, D ;
Kupfer, Y .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7464) :480-484
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   Reversal of late septic shock with supraphysiologic doses of hydrocortisone [J].
Bollaert, PE ;
Charpentier, C ;
Levy, B ;
Debouverie, M ;
Audibert, G ;
Larcan, A .
CRITICAL CARE MEDICINE, 1998, 26 (04) :645-650
[5]   Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study [J].
Briegel, J ;
Forst, H ;
Haller, M ;
Schelling, G ;
Kilger, E ;
Kuprat, G ;
Hemmer, B ;
Hummel, T ;
Lenhart, A ;
Heyduck, M ;
Stoll, C ;
Peter, K .
CRITICAL CARE MEDICINE, 1999, 27 (04) :723-732
[6]   Open access publishing takes off - The dream is now achievable [J].
Delamothe, T ;
Smith, R .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7430) :1-3
[7]  
Dellinger RP, 2008, INTENS CARE MED, V34, P783, DOI [10.1007/s00134-008-1040-9, 10.1097/01.CCM.0000298158.12101.41]
[8]   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :536-555
[9]   Surviving sepsis - Practice guidelines, marketing campaign, and Eli Lilly [J].
Eichacker, Peter Q. ;
Natanson, Charles ;
Danner, Robert L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (16) :1640-1642
[10]   A TRIAL OF GOAL-ORIENTED HEMODYNAMIC THERAPY IN CRITICALLY ILL PATIENTS [J].
GATTINONI, L ;
BRAZZI, L ;
PELOSI, P ;
LATINI, R ;
TOGNONI, G ;
PESENTI, A ;
FUMAGALLI, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (16) :1025-1032